iRhythm Technologies

Product Director, Emerging Platforms

United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Digital Health, Medical Devices, AI in Medicine, Cardiac HealthIndustries

Requirements

Candidates should have experience in Digital Health, Medical Devices, and AI in Medicine, with a passion for driving innovation, product/market fit, and market growth. A strong understanding of the cardiac monitoring space is essential, along with the ability to synthesize clinical, technical, operational, and commercial perspectives. Experience in voice of the customer research, portfolio roadmap development, and managing new features from development through launch is required. The role demands strong cross-functional collaboration skills and the ability to manage product prioritization and business reviews.

Responsibilities

The Product Director will lead the Product Strategy for emerging platforms and solutions, coordinating all ideation and upstream product activities. They will partner closely with Product Management throughout the product development lifecycle for hardware and digital products, ensuring 510(k) readiness and launch readiness across clinical services, operations, and commercial teams. Responsibilities include supporting successful product launches, acting as the clinical, technical, and commercial owner for emerging platforms, coordinating 510(k) submissions and post-submission activities, defining and tracking product health metrics, maintaining a pulse on customer feedback, driving cross-functional teams to meet milestones, and supporting business reviews for emerging platforms and solutions.

Skills

Product Strategy
Digital Health
Medical Devices
AI in Medicine
Product Development
Hardware
Digital Products
Clinical Services
Operations
Market Access
Commercial Strategy
Marketing

iRhythm Technologies

Advanced cardiac monitoring solutions provider

About iRhythm Technologies

iRhythm Technologies focuses on cardiac monitoring solutions, with its main product being the Zio Patch, a wearable device that tracks heart rhythms for up to 14 days. This extended monitoring helps healthcare providers detect irregular heart rhythms that shorter monitoring might miss, making it especially useful for patients at risk. The company serves both patients and healthcare providers, generating revenue by selling the Zio Patch and offering data analysis services to interpret the collected heart data. iRhythm aims to improve patient outcomes and streamline healthcare workflows in the cardiac health sector.

San Francisco, CaliforniaHeadquarters
2006Year Founded
$102.8MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Holidays
401(k) Retirement Plan
401(k) Company Match
Employee Stock Purchase Plan
Mental Health Support
Hybrid Work Options
Pet Insurance

Risks

Increased competition from emerging cardiac monitoring technologies threatens market share.
FDA warning letter may lead to regulatory scrutiny and potential fines.
Shareholder investigation could result in legal challenges and financial liabilities.

Differentiation

Zio Patch offers up to 14 days of uninterrupted cardiac monitoring.
iRhythm's Zio Patch is the smallest and least conspicuous cardiac diagnostic device.
The company provides data analysis services for actionable insights from Zio Patch data.

Upsides

Wearable health tech market growth aligns with iRhythm's business model.
Telehealth expansion increases demand for remote monitoring solutions like Zio Patch.
AI integration enhances arrhythmia detection accuracy in iRhythm's Zio Patch.

Land your dream remote job 3x faster with AI